Given the observed protective effects of PTX3 deficiency against STZ-induced deformation of pancreatic islets and β-cell death, targeting PTX3 may represent a promising strategy for mitigating diabetes-related complications. This evidence concerns the gene PTX3 and diabetes mellitus.